By Rishab Shaju and Ateev Bhandari (Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares ...

According to Ness, the success of HeartFlow’s IPO reflects the market validation of the overall rationale for using AI in ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Heartflow, Inc. (NASDAQ:HTFL) is one of the best-performing stocks on Friday. Heartflow Inc. saw its share prices surge by ...

Heartflow (NASDAQ:HTFL), a MedTech firm backed by private equity firms including Bain Capital, climbed ~50% on its first ...

The stock of medical imaging and diagnostics software company Heartflow jumped 50% in its market debut on Aug. 8; the latest ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Shares of Heartflow opened at $28 on Friday, jumping over 47% above the initial public offering price of $19 per share in their Nasdaq debut. This opening price valued the medical technology company ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Shares of Heartflow are slated to make their trading debut Friday after the coronary-care company's upsized initial public offering was priced above increased expectations.

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized ...

(Reuters) -Heartflow shares surged 47.4% in their Nasdaq debut on Friday, giving the medtech firm a valuation of $2.27 billion, as the IPO market gathers momentum and outrides tariff worries. The ...